27
Views
9
CrossRef citations to date
0
Altmetric
Article

Histopathologic evaluation of a novel‐design nitinol stent: the Biflex stent

, , , &
Pages 13-19 | Received 01 Jul 2003, Accepted 27 Oct 2003, Published online: 10 Jul 2009

References

  • Fischman DL, Leon MB, Bairn DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496–501.
  • Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489–95.
  • Kastrati A, Schomig A, Elezi S et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30: 1428–36.
  • de Feyter PJ, Kay P, Disco C, Serruys PW. Reference chart derived from post-stent-implantation intravascular ultra-sound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 1999; 100: 1777–83.
  • Rogers C, Edelman E. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995; 91: 2995–3001.
  • Kastrati A, Mehilli J, Dirschinger J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001; 103: 2816–21.
  • Briguori C, Sarais C, Pagnotta P et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol 2002; 40: 403–409.
  • Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000; 101: 812–18.
  • Edelman ER, Rogers C. Pathobiologic responses to stent- ing. American Journal of Cardiology 1998; 81: 4E-6E.
  • Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vase Biol 1996; 16: 1312–18.
  • Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thicken- ing in balloon-injured arteries. Arterioscler Thromb Vase Biol 2000; 20: 2553–58.
  • Sheth S, Litvack F, Dev V, Fishbein MC, Forrester JS, Eigler N. Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model. Circulation 1996; 94: 1733–40.
  • Degertekin M, Serruys PW, Foley DP et al. Persistent inhibition of neointimal hyperplasia after sirolimus-elut- ing stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002; 106: 1610–13.
  • Duda SH, Pusich B, Richter G et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002; 106: 1505–509.
  • Beyar R, Henry M, Shofti R, Grenedier E, Globerman O, Beyar M. Self-expandable nitinol stent for cardiovascular applications: canine and human experience. Cathet Cardi- ovasc Diagn 1994; 32: 162–70.
  • Carter AJ, Scott D, Laird JR et al. Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. Cathet Cardiovasc Diagn 1998; 44: 193–201.
  • Hong MK, Beyar R, Kornowski R, Tio FO, Bramwell O, Leon MB. Acute and chronic effects of self-expanding nitinol stents in porcine coronary arteries. Coron Artery Dis 1997; 8: 45–48.
  • Lee KW, Park JH, Chung JW, Kim WS, Lee W, Yeon KM. Short-term effects of a new intravascular nitinol stent in canine arteries. Invest Radiol 1999; 34: 367–73.
  • Yoon CJ, Chung JW, Park JH et al. A newly designed nitinol stent: early clinical experience in the treatment of iliac artery stenoses and occlusions. Kor J Radiol 2001; 2: 145–50.
  • Castleman LS, Motzkin SM. Biocompatibility of nitinol. In: Williams DF ed. Biocompatibility of Clinical Implant Materials. Location, Publisher, 1981.
  • Ing inits, Bierman FZ. Percutaneous transcatheter coil occlusion of the patent ductus arteriosus aided by the nitinol snare: further observations. Cardiovasc Intervent Radiol 1995; 18: 222–26.
  • Farb A, Sangiorgi G, Carter AJ et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44–52.
  • Schwartz RS, Huber KC, Murphy JG et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267–74.
  • van der Giessen WJ, Lincoff AM, Schwartz RS et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690–97.
  • Whelan DM, van der Giessen WJ, Krabbendam SC et al. Biocompatibility of phosporylcholine coated stents in normal porcine coronary arteries. Heart 2000; 83: 338–45.
  • Hiatt BL, Ikeno F, Yeung AC, Carter AJ. Drug-eluting stents for the prevention of restenosis: in quest for the Holy Grail. Cathet Cardiovasc Intervent 2002; 55: 409–17.
  • Johnson SP, Fujitani RM, Leyendecker JR, Joseph FB. Stent deformation and intimal hyperplasia complicating treat-ment of a post-carotid endarterectomy intimal flap with a Palmaz stent. J Vase Surg 1997; 25: 764–68.
  • Mathur A, Dorros G, Iyer SS, Vitek JJ, Yadav SS, Roubin GS. Palmaz stent compression in patients following carotid artery stenting. Cathet Cardiovasc Diagn 1997; 41: 137–40.
  • Schwarzenberg H, Muller-Hulsbeck S, Gluer CC, Wesner F, Heller M. Restenosis of peripheral stents and stent grafts as revealed by intravascular sonography: in vivo comparison with angiography. Am J Roentgen 1998; 170: 1181–85.
  • Henry M, Amor M, Beyar R et al. Clinical experience with a new nitinol self-expanding stent in peripheral arteries. J Endovasc Surg 1996; 3: 369–79.
  • Hausegger KA, Cragg AH, Lammer J et al. Iliac artery stent placement: clinical experience with a nitinol stent. Radi- ology 1994; 190: 199–202.
  • Houston JG, McCollum PT, Stonebridge PA, Raza Z, Shaw JW. Aortic bifurcation reconstraction: use of the Mem- otherm self-expanding nitinol stent for stenoses and occlusions. Cardiovasc Intervent Radiol 1999; 22: 89–95.
  • Holmes DR, Jr, Lansky A, Kuntz R et al. The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions. Am J Cardiol 2000; 86: 1073–79.
  • Kandzari DE, Goldberg S, Schwartz RS, Chazin-Caldie M, Sketch MH, Jr. Investigators SSR. Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Rest- enosis (SCORES) Saphenous Vein Graft Registry. Am Heart J 2003; 145: 868–74.
  • Verheye S, Salame MY, Robinson KA et al. Short- and long- term histopathologic evaluation of stenting using a self- expanding nitinol stent in pig carotid and iliac arteries. Cathet Cardiovasc Intervent 1999; 48: 316–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.